Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» TEV-48574
TEV-48574
Teva suffers setback on in-house asthma program as a PhII study is halted early due to futility
Endpoints
Wed, 03/23/22 - 11:06 am
Teva Pharmaceutical
clinical trials
asthma
TEV-48574